Insomnia, depressive disorder, bipolar disorder, somatoform disorder, epilepsy, stroke convalescence, post-stroke cognitive impairment, hypertension, coronary heart disease
Conditions
Interventions
insomnia group:Niuhuangqingxin Pill
depressive disorder group:Niuhuangqingxin Pill
bipolar disorder group:Niuhuangqingxin Pill
somatoform disorder group:Niuhuangqingxin Pill
epilepsy group:Niuhuangqingxin Pill
stroke group:Niuhuangqingxin Pill
hypertension group:Niuhuangqingxin Pill
coronary heart disease group:Niuhuangqingxin Pill
Sponsors
Guangdong Provincial People's Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Patients meet the diagnosis criteria of one of the following disease: insomnia, depressive disorder, bipolar disorder, somatoform disorder, epilepsy, stroke convalescence, post-stroke cognitive impairment, hypertension, coronary heart disease, including course of treatment and drug combination; 2.Patients who are taking Niuhuangqingxin Pill; 3.Patients who provided voluntary written consent to take part in this study.
Exclusion criteria
Exclusion criteria: 1. Those who are allergic to (administration) Niuhuang Qingxin Pill and its components, or are allergic; 2. Women who are pregnant, planning to become pregnant or breastfeeding; 3. Those who are participating in another clinical trial; 4. The investigator judges that it is not suitable to participate in this trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Insomnia severity Index scale;Hamilton rating scale for depression;young manic rating scale;Health Questionnaire-15;the National Institutes of Health Stroke Scale;Mini-Mental State Examination;Seattle Angina Questionnaire;Seizure frequency(1month);blood pressure;TCM syndrome integral scale; | — |
Countries
China
Contacts
Public ContactJia Fujun
Guangdong Provincial People's Hospital
Outcome results
None listed